GRI BIO
GRI is a development stage biotech company fundamentally changing the way inflammatory disease is treated. GRI’s Natural Killer T (NKT) cell-based therapies are being developed for liver disease and acute liver failure. NKT cells share properties of both NK and T cells and are a functional link between the innate and adaptive immune responses. Type 1 NKT cells play a critical role in initiating and propagating the inflammatory response and the hepatic injury that is observed in liver disease. GRI’s lead program, GRI-0621, is an inhibitor of type I NKT cells and is being developed as a novel oral therapeutic for acute liver failure.
GRI BIO
Social Links:
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2009-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.gribio.com
Total Employee:
1+
Status:
Active
Contact:
(619) 400-1171
Total Funding:
4.38 M USD
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Vybion
Vybion, Inc. is a development stage company.
Current Employees Featured
Founder
Official Site Inspections
http://www.gribio.com
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
